FrancophonIA/ELRC3.0 huggingface dataset:
English: Each ml contains: 1.5 mg of meloxicam, 5 mg of sodium benzoate.
Slovenian: 1 ml vsebuje: 1,5 mg meloksikama 5 mg natrijevega benzoata
English: Do not use in horses suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Slovenian: Ne uporabite pri konjih z obolenji prebavil, kot so razdraženost prebavil in krvavitve, pri motnjah delovanja jeter, srca ali ledvic in pri hemoragičnih obolenjih.
English: In dogs, meloxicam is predominantly found in plasma and is also a major biliary excretion product whereas urine contains only traces of the parent compound.
Slovenian: Meloksikam se pri psih pretežno nahaja v plazmi in je tudi pomembna sestavina pri izločanju zdravila z žolčem, medtem ko vsebuje urin samo sledi matične spojine.
English: EU/2/11/134/003 100 ml EU/2/11/134/004 200 ml
Slovenian: EU/2/11/134/004 200 ml
English: Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg body weight (i.e. 2.5 ml/100 kg body weight) in combination with antibiotic therapy or with oral re-hydration therapy, as appropriate.
Slovenian: (to je 2,5 ml/100 kg telesne mase), po potrebi v kombinaciji z antibiotičnim zdravljenjem ali s peroralno rehidracijsko terapijo.
English: Pharmacotherapeutic group: Anti-inflammatory and anti-rheumatic products, non-steroids (oxicams).
Slovenian: Farmakoterapevtska skupina: nesteroidna protivnetna in protirevmatična zdravila (oksikami).
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Slovenian: Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (http://www.ema.europa.eu0.
English: PACKAGE LEAFLET: Inflacam 15 mg/ml oral suspension for horses
Slovenian: IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Inflacam 15 mg/ml peroralna suspenzija za konje
English: Inflacam 15 mg/ml oral suspension for horses Meloxicam
Slovenian: IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Inflacam 15 mg/ml peroralna suspenzija za konje Meloksikam
English: In very rare cases anaphylactoid reactions which may be serious (including fatal) may occur and should be treated symptomatically.
Slovenian: V zelo redkih primerih se lahko pojavijo anafilaktične reakcije, ki so lahko resne (tudi smrtne) in jih je treba zdraviti simptomatsko.
English: Manufacturers responsible for the batch release: Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway,
Slovenian: Izdelovalec, odgovoren za sproščanje serij Chanelle Pharmaceuticals Manufacturing Ltd. Loughrea, Co. Galway, IRSKA.
English: Cardboard box with 1 colourless glass injection vial containing 20 ml, 50 ml, 100 ml or 250 ml.
Slovenian: Kartonska škatla z 1 brezbarvno stekleno injekcijsko vialo po 20 ml, 50 ml, 100 ml ali 250 ml. Ni nujno, da so v prometu vsa navedena pakiranja.
English: Do not use in dogs suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Slovenian: Ne uporabite pri psih z obolenji prebavil, kot so razdraženost prebavil in krvavitve, pri motnjah delovanja jeter, srca ali ledvic in pri hemoragičnih obolenjih.
English: Do not use in cats suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Slovenian: Ne uporabite pri mačkah z obolenji prebavil, kot so vzdraženost prebavil in krvavitve, pri motnjah delovanja jeter, srca ali ledvic in pri hemoragičnih obolenjih.
English: STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS
Slovenian: NAVEDBA ZDRAVILNE UČINKOVINE IN DRUGIH SESTAVIN
English: Water for injections
Slovenian: FARMACEVTSKA OBLIKA Raztopina za injiciranje
English: EXP {month/year} Once broached, use by…
Slovenian: Načeto/odprto zdravilo uporabite do…
English: ROUTE(S) OF ADMINISTRATION
Slovenian: NAČIN IN POT(I)UPORABE
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu).
Slovenian: Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (http://www.ema.europa.eu).
English: Oral suspension.
Slovenian: FARMACEVTSKA OBLIKA Peroralna suspenzija.
English: Carton for 10 ml, 20 ml and 100 ml vial
Slovenian: PODATKI NA ZUNANJI OVOJNINI {Škatla za 10 ml, 20 ml ali 100 ml vialo}
English: PACKAGE LEAFLET: Inflacam 5 mg/ml solution for injection for dogs and cats
Slovenian: IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Inflacam 5 mg/ml raztopina za injiciranje za pse in mačke
English: Manufacturers responsible for batch release:
Slovenian: Izdelovalec, odgovoren za sproščanje serij
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu
Slovenian: Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (http://www.ema.europa.eu)
English: Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg body weight (i.e. 10 ml/100 kg body weight) in combination with antibiotic therapy or with oral re-hydration therapy, as appropriate.
Slovenian: (to je 10 ml/100 kg telesne mase), po potrebi v kombinaciji z antibiotičnim zdravljenjem ali s peroralno rehidracijsko terapijo.
English: Inflacam 330 mg granules for horses.
Slovenian: IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Inflacam 330 mg zrnca za konje.
English: Cardboard box containing 1 colourless glass injection vial of 20 ml, 50 ml or 100 ml.
Slovenian: Kartonska škatla z 1 brezbarvno stekleno injekcijsko vialo po 20 ml, 50 ml ali 100 ml. Ni nujno, da so v prometu vsa navedena pakiranja.
English: Carton for 20 ml, 50 ml, 100 ml and 250 ml
Slovenian: PODATKI NA ZUNANJI OVOJNINI Škatla za 20 ml, 50 ml, 100 ml ali 250 ml vialo
English: Shelf-life of the veterinary medicinal product as packaged for sale: 30 months Shelf life after first opening the immediate packaging: 3 months.
Slovenian: Rok uporabnosti zdravila v pakiranju za prodajo: 30 mesecev.
English: Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity.
Slovenian: Zaradi nevarnosti toksičnih učinkov na ledvice se dajanju zdravila izogibamo pri dehidriranih, hipovolemičnih ali hipotenzivnih živalih.
English: Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e. 2.0 ml/25 kg body weight).
Slovenian: Enkratna intramuskularna injekcija odmerka po 0,4 mg meloksikama na kilogram telesne mase (to je 2,0
English: Cattle: meat and offal: 15 days.
Slovenian: Govedo: meso in organi: 15 dni Prašiči: meso in organi: 5 dni
English: Inflacam 1.5 mg/ml oral suspension for dogs Meloxicam
Slovenian: IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Inflacam 1,5 mg/ml peroralna suspenzija za pse Meloksikam
English: Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight.
Slovenian: Zdravljenje nadaljujemo z enim peroralnim,-vzdrževalnim odmerkom po 0,1 mg meloksikama na kilogram telesne mase na dan (v 24-urnih presledkih).
English: Dose scheme for the maintenance dose:
Slovenian: DAJANJA ZDRAVILA Odmerjanje
English: In very rare cases anaphylactoid reactions, which may be serious (including fatal), may occur and should be treated symptomatically.
Slovenian: Zelo redko se lahko pojavijo anafilaktoidne reakcije, ki so lahko resne (vključno s smrtnimi) in jih je treba zdraviti simptomatsko.
English: INDICATIONS
Slovenian: ZDRAVILA
English: In this situation, you should inform your doctor as soon as possible.
Slovenian: V tem primeru čim prej obvestite zdravnika.
English: Recommended wording
Slovenian: Priporočeno besedilo
English: Avoid any unnecessary exercise as this might increase the risk of a tendon rupture.
Slovenian: Izogibajte se kakršni koli nepotrebni vadbi, saj lahko poveča tveganje za pretrganje kite.
English: Before taking this medicine
Slovenian: Preden boste vzeli to zdravilo
English: Therefore the following text should be added in Section 4.1 as relevant:
Slovenian: Zato je treba v poglavju 4.1 dodati naslednje besedilo, kot je primerno:
English: Therefore, concomitant use of corticosteroids should be avoided.
Slovenian: Sočasni uporabi kortikosteroidov se je zato treba izogibati.
English: Section 4.8: undesirable effects
Slovenian: Poglavje 4.8: Neželeni učinki
English: Medically incorrect indications
Slovenian: Medicinsko nepravilne indikacije
English: Should medicinal products no longer have any authorised indications with a positive benefit-risk balance then the national competent authorities should take the appropriate action in line with the conclusions on this procedure under Article 31 of Directive 2001/83/EC.
Slovenian: Če zdravila nimajo več dovoljenih indikacij s pozitivnim razmerjem med koristmi in tveganji, morajo nacionalni pristojni organi sprejeti ustrezne ukrepe v skladu z zaključki tega postopka, ki je v skladu z 31. členom Direktive 2001/83/ES.
English: You and your doctor will decide on continuing the treatment considering also an antibiotic from another class.
Slovenian: Skupaj z zdravnikom se boste odločili o nadaljnjem zdravljenju, morebiti tudi z antibiotikom iz kakšne druge skupine.
English: The product information may be subsequently updated by the Member State competent authorities, in liaison with the reference Member State, as appropriate, in accordance with the procedures laid down in Chapter 4 of Title III of Directive 2001/83/EC.
Slovenian: Informacije o zdravilu bodo morda pristojni organi držav članic v sodelovanju z referenčno državo članico kasneje posodobili, če je primerno, v skladu s postopki opredeljenimi v poglavju 4 naslova III Direktive 2001/83/ES.
English: Recommended wording of category 1 indications
Slovenian: Priporočeno besedilo za indikacije kategorije 1
English: When taking this medicine
Slovenian: Med jemanjem tega zdravila
English: The following new warning should be included at the beginning of the warning statements on safety issues:
Slovenian: Naslednje novo opozorilo je treba vključiti na začetku opozorilnih stavkov o pomislekih glede varnosti:
English: Section 4.1: therapeutic indications
Slovenian: Poglavje 4.1: Terapevtske indikacije
English: If this happens, stop taking <product name> and inform your doctor immediately in order to prevent the development of potentially irreversible condition.
Slovenian: Če se to zgodi, prenehajte jemati zdravilo <ime zdravila> in o tem takoj obvestite zdravnika, da preprečite razvoj potencialno ireverzibilnega stanja.
English: Tuberculosis
Slovenian: • Tuberkuloza
English: Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Slovenian: Pri zdravljenju je treba upoštevati uradne smernice o pravilni uporabi protibakterijskih zdravil.
English: For systemically administered levofloxacin containing products the listing of risk factors within the first above mentioned sentence should additionally include “in patients receiving daily doses of 1000 mg levofloxacin”.
Slovenian: Za sistemsko uporabljena zdravila, ki vsebujejo levofloksacin, mora navedba o dejavnikih tveganja v prvem zgoraj navedenem stavku dodatno vsebovati »pri bolnikih, ki prejemajo dnevne odmerke 1000 mg levofloksacina«.
English: Section 2 Warnings and precautions
Slovenian: Poglavje 2: Opozorila in previdnostni ukrepi
English: Note: the indications are grouped under headings or cover terms that encompass the same medical entity; all changes apply to both the cover term and sub-headings, as relevant.
Slovenian: Opomba: indikacije so združene pod naslovi ali skupnimi izrazi za enaka zdravstvena stanja; vse spremembe se nanašajo na oboje, na skupni izraz in podnaslove, kot je ustrezno.
English: Your risk is increased if you are elderly (above 60 years of age), have received an organ transplant, have kidney problems or if you are being treated with corticosteroids.
Slovenian: Tveganje je povečano, če ste starejši (stari več kot 60 let), so vam presadili organ, imate težave z ledvicami ali se zdravite s kortikosteroidi.
English: Inflammation and ruptures of tendons may occur within the first 48 hours of treatment and even up to several months after stopping of <product name> therapy.
Slovenian: Vnetje in pretrganja kit se lahko pojavijo že v prvih 48 urah zdravljenja, lahko pa tudi več mesecev po prenehanju zdravljenja z zdravilom <ime zdravila>.
English: These infections include cystitis,
Slovenian: Te okužbe vključujejo cistitis,
English: Endocarditis
Slovenian: Endokarditis
English: • Sepsis due to above-mentioned genito-urinary infections
Slovenian: • Sepsa zaradi zgoraj omenjenih genitourinarnih okužb
English: These amendments to the relevant sections of the product information are the outcome of the referral procedure.
Slovenian: Te spremembe ustreznih poglavij informacij o zdravilu so bile dogovorjene v postopku napotitve.
English: In addition of the amendments recommended below, the following sentence should be included in all quinolones and fluoroquinolones containing medicinal products at the end of section 4.1:
Slovenian: Poleg spodaj priporočenih sprememb je treba pri vseh zdravilih, ki vsebujejo kinolone in fluorokinolone, na koncu poglavja 4.1 vključiti naslednji stavek:
English: • Acute and chronic prostatitis, including severe forms
Slovenian: • Akutni in kronični prostatitis, vključno s hudimi oblikami
English: The use of [INN] should be avoided in patients who have experienced serious adverse reactions in the past when using quinolone or fluoroquinolone containing products (see section 4.8).
Slovenian: Uporabi [INN] se je treba izogibati pri bolnikih, pri katerih so se v preteklosti med uporabo zdravil, ki vsebujejo kinolone ali fluorokinolone, pojavili resni neželeni učinki (glejte poglavje 4.8).
English: Tuberculosis, in combination treatment
Slovenian: • Tuberkuloza, pri kombiniranem zdravljenju
English: The current warning statement on tendinopathies/tendon disorders should be amended with regard to risk factors, time to onset and need for monitoring of patients and should include at least the following information (or added as new statement if missing):
Slovenian: Trenutni opozorilni stavek o tendinopatijah/poškodbah kit je treba popraviti glede dejavnikov tveganja, časa do pojava in potrebe po spremljanju bolnikov, in mora vključevati vsaj naslednje informacije (ali ga dodati kot novo besedilo, če manjka):
English: Corticosteroids should not be used if signs of tendinopathy occur.
Slovenian: Če se pojavijo znaki tendinopatije, se ne sme uporabiti kortikosteroidov.
English: Prevention of infection in surgical procedures
Slovenian: Preprečevanje okužb pri kirurških postopkih
English: Treatment of these patients with [INN] should only be initiated in the absence of alternative treatment options and after careful benefit/risk assessment (see also section
Slovenian: Zdravljenje teh bolnikov s/z [INN] se sme uvesti le v primeru, da ni drugih možnosti zdravljenja, in po skrbni oceni razmerja med koristmi in tveganji (glejte tudi poglavje 4.3).
English: If you experience any of these side effects after taking [Name of product], contact your doctor immediately prior to continuing treatment.
Slovenian: Če se po jemanju zdravila [ime zdravila] pojavi kateri koli od teh neželenih učinkov, se takoj posvetujte z zdravnikom, preden nadaljujete z zdravljenjem.
English: The following warning should be included:
Slovenian: Vključiti je treba naslednje opozorilo:
English: [INN] should be discontinued immediately at the first signs or symptoms of any serious adverse reaction and patients should be advised to contact their prescriber for advice.
Slovenian: Zdravljenje z [INN] je treba prenehati takoj ob prvih znakih ali simptomih kakršnih koli resnih neželenih učinkov, bolniku pa je treba svetovati, naj se posvetuje z zdravnikom, ki mu je zdravilo predpisal.
English: Tendinitis and tendon rupture (especially but not limited to Achilles tendon), sometimes bilateral, may occur as early as within 48 hours of starting treatment with quinolones and fluoroquinolones and have been reported to occur even up to several months after discontinuation of treatment.
Slovenian: Tendinitis in ruptura kite (zlasti, a ne izključno, Ahilove tetive), včasih obojestransko, se lahko pojavita že v 48 urah po začetku zdravljenja s kinoloni in fluorokinoloni, o njiju pa so poročali tudi še več mesecev po prenehanju zdravljenja.
English: Section 4.4: special warnings and precautions for use
Slovenian: Poglavje 4.4: Posebna opozorila in previdnostni ukrepi
English: Prolonged, disabling and potentially irreversible serious adverse drug reactions
Slovenian: Dolgotrajni, onesposabljajoči in potencialno ireverzibilni resni neželeni učinki
English: At the first sign of tendinitis (e.g. painful swelling, inflammation) the treatment with [INN] should be discontinued and alternative treatment should be considered.
Slovenian: Ob prvem znaku tendinitisa (npr. boleča oteklina, vnetje) je treba zdravljenje s/z [INN] prenehati in razmisliti o drugačnem zdravljenju.
English: The risk of tendinitis and tendon rupture is increased in older patients, patients with renal impairment, patients with solid organ transplants, and those treated concurrently with corticosteroids.
Slovenian: Tveganje za tendinitis in rupturo kite je povečano pri starejših bolnikih, bolnikih z okvaro ledvic, bolnikih s presajenimi organi in pri tistih, ki se sočasno zdravijo s kortikosteroidi.
English: An asterisk should be added to the title of selected SOCs as follows: Musculoskeletal and connective tissue disorders* Nervous system disorders*
Slovenian: K naslovu izbranih organskih sistemov je treba dodati zvezdico, kot sledi: Bolezni mišično-skeletnega sistema in vezivnega tkiva* Bolezni živčevja*
English: The affected limb(s) should be appropriately treated (e.g. immobilisation).
Slovenian: Prizadeto okončino ali okončine je treba ustrezno oskrbeti (npr. imobilizacija).
English: • Immunocompromised patients: o Infections in neutropenic patients (as prophylaxis).
Slovenian: • Imunokompromitirani bolniki: o Okužbe pri nevtropeničnih bolnikih (kot profilaksa).
English: • Complicated intra-abdominal infections.
Slovenian: • Zapletene intraabdominalne okužbe.
English: At the first sign of pain or inflammation of a tendon (for example in your ankle, wrist, elbow, shoulder or knee), stop taking <product name>, contact your doctor and rest the painful area.
Slovenian: Ob prvem znaku bolečine ali vnetja kite (na primer v gležnju, zapestju, komolcu, rami ali kolenu) prenehajte jemati zdravilo <ime zdravila>, posvetujte se z zdravnikom in pustite, da prizadeti ud miruje.
English: The indications in the table below should be deleted for all quinolones/ fluoroquinolones containing products Pharyngitis-Tonsillitis
Slovenian: Indikacije, ki so navedene v spodnji preglednici, je treba izbrisati pri vseh zdravilih, ki vsebujejo kinolone/fluorokinolone Faringitis - tonzilitis
English: The following new warning should be included:
Slovenian: Vključiti je treba naslednje novo opozorilo:
English: • Bacterial prostatitis Children and adolescents
Slovenian: • Bakterijski prostatitis Otroci in mladostniki
English: • Infection in immunocompromised patients
Slovenian: • Okužbe pri imunokompromitiranih bolnikih
English: General disorders and administrative site conditions* Psychiatric disorders*
Slovenian: Splošne težave in spremembe na mestu aplikacije* Psihiatrične motnje*
English: Infection of cerebrospinal fluid
Slovenian: Okužba cerebrospinalne tekočine
English: • Acute sinusitis (last line)
Slovenian: • Akutni sinusitis (zadnja izbira)
English: • Infections of bone and joints (osteomyelitis caused by gram-negative microorganisms)
Slovenian: • Okužbe kosti in sklepov (osteomielitis, ki ga povzročajo gramnegativni mikroorganizmi)
English: The warning about peripheral neuropathies should be included/amended as follows:
Slovenian: Vključiti/spremeniti je treba opozorilo o perifernih nevropatijah, kot sledi:
English: • Ciprofloxacin may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection
Slovenian: • Ciprofloksacin se lahko uporablja za zdravljenje nevtropeničnih bolnikov s povišano telesno temperaturo, če obstaja sum, da je posledica bakterijske okužbe
English: • Alternative form of treatment for bone and joint infections
Slovenian: • Alternativna oblika zdravljenja za okužbe kosti in sklepov
English: Nosocomial pneumonia
Slovenian: Nozokomialna pljučnica
English: You should not take fluoroquinolone/quinolone antibacterial medicines, including [product name], if you have experienced any serious adverse reaction in the past when taking a quinolone or fluoroquinolone.
Slovenian: Protibakterijskih zdravil, ki vsebujejo fluorokinolone/kinolone, vključno z zdravilom [ime zdravila], ne smete jemati, če so se vam pri jemanju fluorokinolonov ali kinolonov že kdaj pojavili kakršni koli resni neželeni učinki.
English: • Post-exposure prophylaxis and curative treatment of anthrax.
Slovenian: • Profilaksa po izpostavljenosti in kurativno zdravljenje antraksa.
English: • Urethritis and cervicitis due to bacteria susceptible to fluoroquinolones
Slovenian: • Uretritis in cervicitis zaradi bakterij, občutljivih na fluorokinolone
English: • Pelvic inflammatory disease, in combination with other antibacterial agents
Slovenian: • Medenična vnetna bolezen, v kombinaciji z drugimi protibakterijskimi zdravili
English: Prolonged, disabling and potentially irreversible serious side effects Fluoroquinolone/quinolone antibacterial medicines, including [product name], have been associated with very rare but serious side effects, some of them being long lasting (continuing months or years), disabling or potentially irreversible.
Slovenian: Dolgotrajni, onesposabljajoči, potencialno ireverzibilni resni neželeni učinki Protibakterijska zdravila, ki vsebujejo fluorokinolone/kinolone, vključno z zdravilom [ime zdravila], so bila povezana z zelo redkimi, a resnimi neželenimi učinki, od katerih so bili nekateri dolgotrajni (trajali so več mesecev ali let), onesposabljajoči ali potencialno ireverzibilni.
English: Annex III Amendments to relevant sections of the product information
Slovenian: Spremembe, ki jih je treba vključiti v ustrezna poglavja informacij o zdravilu
English: • Gonorrhoea • Gonococcal urethritis in humans
Slovenian: • Gonoreja • Gonokokni uretritis pri ljudeh
English: Ear, nose and throat infections o Ear, nose and throat infections (with the exception of acute tonsillitis)
Slovenian: • Okužbe ušes, nosu in žrela o Okužbe ušes, nosu in žrela (z izjemo akutnega tonzilitisa)
English: • Acute prostatitis
Slovenian: • Akutni prostatitis
English: • Salmonella infections (carrier)
Slovenian: • Okužbe s salmonelo (nosilci okužbe)
English: • Pneumonia o Pneumonia, especially when caused by so-called "problematic" germs such as: E. coli, Klebsiella, Enterobacter, Proteus, Pseudomonas, Legionella or Staphylococcus o Pneumonia, above all if it's caused by bacteria such as Escherichia coli, Klebsiella, Enterobacter, Proteus, Pseudomonas, Legionella or Staphylococcus
Slovenian: • Pljučnica o Pljučnica, zlasti, če jo povzročajo tako imenovani »problematični« povzročitelji, kot so: E. coli, Klebsiella, Enterobacter, Proteus, Pseudomonas, Legionella ali Staphylococcus o Pljučnica, zlasti, če jo povzročajo bakterije, kot so Escherichia coli, Klebsiella, Enterobacter, Proteus, Pseudomonas, Legionella ali Staphylococcus
English: The indications in the table below should be restricted for all quinolones/ fluoroquinolones containing products in order to be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections.
Slovenian: Indikacije v spodnji preglednici je treba omejiti pri vseh zdravilih, ki vsebujejo kinolone/fluorokinolone, da bi se uporabljala samo, kadar je uporaba drugih protibakterijskih zdravil, ki se običajno priporočajo za zdravljenje teh okužb, neustrezna.